Exopharm
Exopharm is a regenerative medicine biopharmaceutical company spun out of Altnia Group. Founded in 2003 and based in Melbourne, Australia, the company aims to develop and commercialize exosomes as therapeutic agents.
All edits
Exopharm's proprietary LEAP TechnologyLEAP Technology provides a key step in the downstream manufacturing process to isolate and purify exosomes from adult stem cells and other sources which claims to address existing limitations in exosome purification processes. Exopharm's technology is designed for the manufacture of a proprietary exosome product at clinical and then pharmaceutical grade and scale.
Exopharm's products include Plexaris, exosomes derived from human platelets, and Exomeres, exosomes from stem cellsstem cells.Exosomes are extracellular vesicles involved in cell-cell communication and transmission of disease states through transfer of protein, RNA, lipids and microRNA. Exosomes are thought to mediate some of the regenerative effects of stem cells and provide a cell-free therapeutic agent with therapeutic benefits.The company aims to treat diseases such as dry Age Related Macular Degeneration (AMD), tendinopathy, arthritis, cardiac repair, neurodegeneration and aging.
Introduction to Exopharm.
Find more companies like Exopharm
